Abstract
Nanoparticles composed of therapeutic drugs are suggested as a promising approach for improved drug delivery to tumour cells. Herein, we report the synthesis of 5-fluorouracil (5-FU) encapsulated chitosan (C) functionalized gold (G) nanoparticles (CG5-FU-NPs) and a folate (F) linked counterpart (FCG5-FU-NPs) for enhanced anticancer effects with reduced adverse reactions. Ionic complexation was used to accomplish 5-FU–excipient interaction and the drug encapsulation efficiencies of the nanoparticles were determined appropriately. UV–visible spectroscopy, TEM, FTIR and nanoparticle tracking analysis (NTA) were used to determine the physiochemical properties of the NPs. Also, dynamic dialysis method was used to determine the rate of drug release at simulated tumour and physiological pH conditions. Cell viability was investigated by the MTT assay in human breast adenocarcinoma (MCF-7), hepatocellular carcinoma (HepG2) and kidney (HEK293) cells. CG5-FU-NPs and FCG5-FU-NPs presented as spherical nanoparticles with a size range of 31–33 nm, and showed surface plasmon resonance bands (SPR) between 520 and 525 nm, thus confirming the synthesis of G-NPs. FTIR spectroscopy confirmed the presence of chitosan and folate chitosan on the nanoparticles. CG5-FU-NPs and FCG5-FU-NPs were highly stable as suggested by zeta measurements of approximately + 61.9 mV and + 57.9 mV, respectively. The NPs attained a drug encapsulation efficiency of > 70%, and produced a pH dependent release of 5-FU. Furthermore, both NPs exhibited an enhanced tumour-specific cytotoxicity compared to the free drug, with FCG5-FU-NPs showing significant targeted delivery potential to the folate receptor-positive MCF-7 cells. These results suggest that CG5-FU-NPs and FCG5-FU-NPs are promising therapeutic systems for cancer management.
Similar content being viewed by others
References
Akinyelu J, Singh M (2018) Chitosan stabilized gold-folate-poly (lactide-co-glycolide) nanoplexes facilitate efficient gene delivery in hepatic and breast cancer cells. J Nanosci Nanotechnol 18:4478–4486
Bertrand N, Wu J, Xu X, Kamaly N, Farokhzad OC (2014) Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev 66:2–25
Božanić DK, Trandafilović LV, Luyt AS, Djoković V (2010) ‘Green’synthesis and optical properties of silver–chitosan complexes and nanocomposites. React Funct Polym 70:869–873
Carbinatto FM, de Castro AD, Evangelista RC, Cury BS (2014) Insights into the swelling process and drug release mechanisms from cross-linked pectin/high amylose starch matrices. Asian J Pharm Sci 9:27–34
Chakravarthi SS, Robinson DH (2011) Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Int J Pharm 409:111–120
Chen B, Le W, Wang Y, Li Z, Wang D, Ren L, Lin L, Cui S, Hu JJ, Hu Y, Yang P (2016) Targeting negative surface charges of cancer cells by multifunctional nanoprobes. Theranostics 11:1887
Danhier F, Feron O, Préat V (2010) To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J Control Release 148:135–146
Dash S, Murthy PN, Nath L, Chowdhury P (2010) Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 67:217–223
Dauthal P, Mukhopadhyay M (2016) Noble metal nanoparticles: plant-mediated synthesis, mechanistic aspects of synthesis, and applications. Ind Eng Chem Res 55:9557–9577
Devendiran RM et al (2016) Green synthesis of folic acid-conjugated gold nanoparticles with pectin as reducing/stabilizing agent for cancer theranostics. RSC Adv 6:29757–29768
Dhar S, Reddy EM, Shiras A, Pokharkar V, Prasad BE (2008) Natural gum reduced/stabilized gold nanoparticles for drug delivery formulations chemistry-A. Eur J 14:10244–10250
Dhas NL, Ige PP, Kudarha RR (2015) Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer. Powder Technol 283:234–245
Haiss W, Thanh NT, Aveyard J, Fernig DG (2007) Determination of size and concentration of gold nanoparticles from UV–Vis. spectra. Anal Chem 79:4215–4221
Ismail ST, Al-Kotaji MM, Khayrallah AA (2017) Formulation and evaluation of nystatin microparticles as a sustained release system. Iraqi J Pharm Sci 24:1–10
Kang B-S et al (2017) Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated. PLGA Nanoparticles Carbohydr Polym 159:39–47
Kuksal A, Tiwary AK, Jain NK, Jain S (2006) Formulation and in vitro, in vivo evaluation of extended-release matrix tablet of zidovudine: influence of combination of hydrophilic and hydrophobic matrix formers. AAPS PharmSciTech 7:E1–E9
Lazarus GG, Singh M (2016) Cationic modified gold nanoparticles show enhanced gene delivery in vitro. Nanotechnol Rev 5:425–434
Lee SJ, Min HS, Ku SH, Son S, Kwon IC, Kim SH, Kim K (2014) Tumor-targeting glycol chitosan nanoparticles as a platform delivery carrier in cancer diagnosis therapy. Nanomedicine 9:1697–1713
Madhusudhan A, Reddy GB, Venkatesham M, Veerabhadram G, Kumar DA, Natarajan S, Yang MY, Hu A, Singh SS (2014) Efficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan. Int J Mol Sci 15:8216–8234
Maiyo F, Moodley R, Singh M (2016) Cytotoxicity, antioxidant and apoptosis studies of quercetin-3-O glucoside and 4-(β-D-glucopyranosyl-1→ 4-α-L-rhamnopyranosyloxy)-benzyl isothiocyanate from Moringa oleifera. Anticancer Agents Med Chem 16:648–656
Maney V, Singh M (2017) An in vitro assessment of chitosan/bimetallic PtAu nanocomposites as delivery vehicles for doxorubicin. Nanomedicine 12:2625–2640
Nivethaa E, Dhanavel S, Narayanan V, Vasu CA, Stephen A (2015) An in vitro cytotoxicity study of 5-fluorouracil encapsulated chitosan/gold nanocomposites towards MCF-7 cells. RSC Adv 5:1024–1032
Ofokansi KC, Adikwu MU, Okore VC (2007) Preparation and evaluation of mucin-gelatin mucoadhesive microspheres for rectal delivery of ceftriaxone sodium. Drug Develop Ind Pharm 33:691–700
Parker WB, Cheng YC (1990) Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48:381–395
Pauliukaite R, Ghica ME, Fatibello-Filho O, Brett CM (2010) Electrochemical impedance studies of chitosan-modified electrodes for application in electrochemical sensors and biosensors. Electrochim Acta 55:6239–6247
Ritger PL, Peppas NA (1987) A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–42
Safwat MA, Soliman GM, Sayed D, Attia MA (2016) Gold nanoparticles enhance 5-fluorouracil anticancer efficacy against colorectal cancer cells. Int J Pharm 513:648–658
Salar RK, Kumar N (2016) Synthesis and characterization of vincristine loaded folic acid–chitosan conjugated nanoparticles. Res-Effic Technol 2:199–214
Samadian H, Hosseini-Nami S, Kamrava SK, Ghaznavi H, Shakeri-Zadeh A (2016) Folate-conjugated gold nanoparticle as a new nanoplatform for targeted cancer therapy. J Cancer Res Clin Oncol 142:2217–2229
Singh J, Roychoudhury A, Srivastava M, Solanki PR, Lee DW, Lee SH, Malhotra B (2014) A dual enzyme functionalized nanostructured thulium oxide based interface for biomedical application. Nanoscale 6:1195–1208
Song H, Su C, Cui W, Zhu B, Liu L, Chen Z, Zhao L (2013) Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery. BioMed Res Int 2013:723158
Sood A, Panchagnula R (1998) Drug release evaluation of diltiazem CR preparations International. J Pharm 175:95–107
Steichen SD, Caldorera-Moore M, Peppas NA (2013) A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics European. J Pharm Sci 48:416–427
Tan Q, Chu Y, Bie M, Wang Z, Xu X (2017) Preparation and investigation of amphiphilic block copolymers/fullerene nanocomposites as nanocarriers for Hydrophobic. Drug Mater 10:92
Turkevich J, Stevenson PC, Hillier J (1951) A study of the nucleation and growth processes in the synthesis of colloidal gold. Discuss Faraday Soc 11:55–75
Udofot O, Affram K, Bridg’ette Israel EA (2015) Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines. Integr Cancer Sci Ther 2:245
Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM (1999) Polymeric systems for controlled drug release. Chem Rev 99:3181–3198
Upadhyaya L, Singh J, Agarwal V, Pandey A, Verma SP, Das P, Tewari R (2015) Efficient water soluble nanostructured ZnO grafted O-carboxymethyl chitosan/curcumin-nanocomposite for cancer therapy. Process Biochem 50:678–688
Venkatpurwar V, Shiras A, Pokharkar V (2011) Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study. Int J Pharm 409:314–320
Wang C, Shaw LL (2014) On synthesis of Fe2SiO4/SiO2 and Fe2O3/SiO2 composites through sol–gel and solid state reactions. J Sol-gel Sci Technol 72:602–614
Yang C-L, Chen J-P, Wei K-C, Chen J-Y, Huang C-W, Liao Z-X (2017) Release of doxorubicin by a folate-grafted, chitosan-coated magnetic nanoparticle. Nanomaterials 7:85
Yassin AEB, Anwer MK, Mowafy HA, El-Bagory IM, Bayomi MA, Alsarra IA (2010) Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci 7:398
Acknowledgements
The authors acknowledge the funding received from the National Research Foundation (NRF) [M Singh-Grant no: 81289], South Africa.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Akinyelu, J., Singh, M. Folate-tagged chitosan-functionalized gold nanoparticles for enhanced delivery of 5-fluorouracil to cancer cells. Appl Nanosci 9, 7–17 (2019). https://doi.org/10.1007/s13204-018-0896-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13204-018-0896-4